Home›Companies›Biotech & Pharma›Prana Therapies

Prana Therapies, Inc.

Develops antibody medicines for people with respiratory and skin diseases.

Updated Nov 9, 2026·Latest SEC filing Aug 10, 2026·Suggest an edit

About Prana Therapies

Prana Therapies is a private company based in Encinitas, California, incorporated in 2021 in Delaware. It has reported $45,226,932 raised in two offerings on Form D since July 2024. Its chief executive is Sheila Gujrathi, M.D..

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Nov 25, 2025Aug 10, 2026$40,226,932fully sold9$4.4MEquity, Options, Securities on exerciseRule 506(b)Form D ↗
May 30, 2024Jul 19, 2024$5,000,000of $9.0M target2$2.5MOptions, Securities on exerciseRule 506(b)Form D ↗
Total, two offerings$45,226,932

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Prana Therapies's Form D filed Aug 10, 2026.

BA
Ben Auspitz
Director
SD
Sheila Gujrathi, M.D.
Chief Executive Officer and director
Hector Ortega
Hector Ortega
Chief Medical Officer
Ryan Sullivan
Ryan Sullivan
Chief Scientific Officer
AB
Alexis Borisy
Director
Also an executive officer at Curie Bio Seed.

Earlier filings also listed Sheila Gujrathi (founder & ceo, director, last listed Jul 2024) and Miguel Sanjuan (executive officer and director, last listed Jul 2024).

Sources

  1. SECPrana Therapies, Inc. filing history